Le Lézard
Classified in: Business
Subject: STOCK/OTHER MARKET NEWS

Joe Caltabiano Announces Holdings in Cresco Labs Inc.


CHICAGO, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Joe Caltabiano announced today that, in connection with the business combination (the "Business Combination") completed on November 30, 2018 among certain parties, including Cresco Labs Inc. (the "Company") and Cresco Labs, LLC ("Cresco"), Mr. Caltabiano, directly or indirectly, acquired ownership of:

Following the Business Combination, Mr. Caltabiano and the entities under the control and direction of Mr. Caltabiano continue to hold an aggregate of  16,467,920 units of Cresco (the "Redeemable Units"), which are ultimately convertible into 16,467,920 Subordinate Voting Shares of the Company.

Immediately prior to the completion of the Business Combination, Mr. Caltabiano did not own or exercise control or direction over any securities of the Company. The Proportionate Voting Shares and Redeemable Units represent, on an as-converted to Subordinate Voting Share-basis, 45.61% of the issued and outstanding Subordinate Voting Shares (assuming the conversion only of those convertible securities held by Mr. Caltabiano and not of any other convertible securities of the Company), and 6.79% of outstanding Subordinate Voting Shares on a fully diluted basis.

Mr. Caltabiano holds and controls his shares of the Company for investment purposes only and Mr. Caltabiano may increase or decrease his beneficial ownership or control over the shares of the Company, which he may do, from time to time, depending on market or other conditions and to the extent deemed advisable in light of his general investment strategy. The Super Voting Shares held by Mr. Caltabiano and certain other founders of Cresco are designed to ensure that such individuals have voting control at meetings of shareholders of the Company. The Super Voting Shares are subject to the provisions of the investment agreement among the Company, Mr. Caltabiano, and such other founders, as described in the Company's listing statement dated November 30, 2018, which is posted and filed under the Company's profile on www.sedar.com.

This news release is being disseminated as required by National Instrument 62-103 - The Early Warning System and Related Take-Over Bids and Insider Reporting Issues in connection with the anticipated filing of an early warning report (the "Early Warning Report"). A copy of the Early Warning Report will be available on SEDAR under the Company's issuer profile at www.sedar.com and can be obtained by contacting the Company as set out below.

For further information please contact:

John Schetz, General Counsel, Cresco Labs Inc.
520 W Erie St #220,
Chicago, IL 60654
USA

Phone: (312) 410-8226
Email: [email protected]


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:39
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:35
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...

at 19:14
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...



News published on and distributed by: